International Congress Amsterdam 2015

Saturday, 26.09.2015 Sunday, 27.09.2015 Monday, 28.09.2015 Tuesday, 29.09.2015 Wednesday, 30.09.2015		Sponsored symposia: Evening Symposium organised by Novartis Pharma AG: "IgE-mediated asthma: New revelations and future insights" Evening Symposium organised by Boehringer Ingelheim International GmbH: "The challenge of treating uncontrolled asthma on Step 3 and higher: Comparing options" Industry early morning symposium organised by Novartis Pharma AG: "Multidisciplinary approaches in the personalized care of the ALK + NSCLC patient"

Citations should be made in the following way: Authors. Title. Eur Respir J 2015; 46: Suppl. 59, abstract number.

Practising personalised medicine: why, when, and how?

Symposium
Chairs: Catherine Greene (Dublin, Ireland), Claus Vogelmeier (Marburg, Germany)
Aims: To provide novel clinical insights in personalised medicine strategies for important pulmonary diseases, describe new and promising concepts relating to these diseases for the near future and discuss the impact of these developments on clinical practice and healthcare system finances.
Target audience: Scientists, clinician-scientists, and pulmonary physicians.

Download all media

Asthma: are we already there? Ian Douglas Pavord (Oxford, United Kingdom)
Pulmonary hypertension: what can we learn from studies? Marc Humbert (Paris, France)